Latest Vaidya Sane Ayurved Laboratories stock price
Vaidya Sane Ayurved Laboratories P/E Ratio
MADHAVBAUG • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
41.08
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
41.08
Current Price
₹
EPS (TTM)
₹1.88
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.49
Sector Median
30.38
Sector Rank
#11 of 131
Sector Percentile
8.4%
Earnings Breakdown (TTM)
TTM EPS
₹8.32
Sept 2023
₹1.12
Jun 2023
₹2.60
Key P/E Ratio Insights for Vaidya Sane Ayurved Laboratories
- Stock appears overvalued with PE of 41.08, suggesting caution for new investments
- Trading at discount to sector average PE of 53.49
View the MADHAVBAUG equity price for detailed stock performance.
Related Pages for Vaidya Sane Ayurved Laboratories
Additional stock information and data for MADHAVBAUG
Sector P/E Ratio Comparison
Comparing Vaidya Sane Ayurved Laboratories with other companies in Healthcare sector
Sector Average
53.49
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |